1. What is the sFlt-1 test?
The sFlt-1 test measures soluble FMS-like tyrosine kinase 1 in blood, a key marker related to placental function during pregnancy.
2. Why is sFlt-1 testing recommended in pregnancy?
It is recommended to assess risk of preeclampsia and placental insufficiency, especially in high-risk or symptomatic pregnancies.
3. Who should take the sFlt-1 test?
It is advised for pregnant women with high blood pressure, swelling, severe headache, visual disturbances, or abnormal pregnancy monitoring reports.
4. What does high sFlt-1 indicate?
High sFlt-1 levels may suggest increased risk of preeclampsia and reduced placental blood flow, requiring close pregnancy monitoring.
5. What is the sFlt-1/PlGF ratio?
It is a calculated ratio using sFlt-1 and PlGF values that helps doctors better predict or rule out preeclampsia risk.
6. Can sFlt-1 test confirm preeclampsia?
It supports risk prediction and monitoring, but final diagnosis depends on BP readings, clinical symptoms, urine protein, and other tests.
7. Is fasting required for the sFlt-1 test?
No, fasting is not required for this test.
8. How is the sample collected?
It is a blood test, and sample can be collected at a lab or through FREE home sample collection by BookMyTest.